NATURAL HEALTH TRENDS CORP

NHTC

$16M

Micro Cap

NASDAQWholesale-Miscellaneous Nondurable Goods🇺🇸North AmericaROLLING HILLS ESTATES133 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

NHTC News

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How NHTC's past catalysts played out

earningsNov 2025-23%earningsMay 2023-10%earningsMay 2020+8%earningsMar 2020-7%earningsAug 2019+13%earningsApr 2019+5%earningsMay 2018+6%

Drug Pipeline

Heptex

Phase 2

Nonalcoholic Steatohepatitis

Drug Name	Phase	Indication	Designations	Patent
Heptex	Phase 2	Nonalcoholic Steatohepatitis	-	-

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

What is in NATURAL HEALTH TRENDS CORP's drug pipeline?→

CatalystAlert tracks 1 drug candidate in NATURAL HEALTH TRENDS CORP's (NHTC) pipeline across Phase 2. Its lead program is Heptex (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is NATURAL HEALTH TRENDS CORP's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for NATURAL HEALTH TRENDS CORP (NHTC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track NHTC biotech catalysts?→

Add NHTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NATURAL HEALTH TRENDS CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply